Recipharm founder to lead Amarna boardAmarna Therapeutics has appointed a new Supervisory Board, led by healthcare and biotech pioneer Thomas Eldered. more ➔
EIT Innovator Award: Marc Julien awardedDiabeloop CEO Marc Julien has won the EIT Innovators Award. more ➔
iOmx: Papadimitriou at the helmiOmx Therapeutics AG has named Apollon Papadimitriou as Chief Executive Officer. more ➔
QIAGEN: Temporary CEOAfter the departure of Peer Schatz, Thierry Bernard is taking over as interim Chief Executive Officer at QIAGEN while the molecular diagnostics company is looking for a permanent head. more ➔
Oerth Bio: Joint venture CEOJohn Dombrosky is taking over the helm of the newly founded Oerth Bio, a targeted protein degradation joint venture launched by Bayer and US biotech Arvinas. more ➔
Solentim: Blending biology and businessIt is a brand-new role at Bournemouth-based Life Sciences company Solentim: Mark Stockdale will join the global leader in cell line development instrumentation as as Amalgamator of Business and Biol … more ➔
Patrice Ferrand named new Biom’up CE...Biom’up SA, specialising in surgical hemostasis, appointed Patrice Ferrand as their new CEO. Ferrand replaces Jan Ohrstrom, who was appointed CEO since May and remains Chairman of the Board. more ➔
H.E.L. Group: Realising market potentialH.E.L. Group Ltd has a new CEO: The global manufacturer of laboratory tools for process optimisation, safety and scale-up announced the appointment of Louise Madden as Chief Executive Officer. more ➔
Lytix Biopharma: Rekdal returns as CEO Edwin Klumper of Lytix Biopharma has stepped down from his role as CEO. The board has decided to promote Head of R&D Øystein Rekdal to the position of CEO. more ➔
Jane Osbourn joins Mogrify Board British cell therapy expert Mogrify Ltd has appointed Jane Osbourn as Chair of the Board. Osbourn will also become a Member of the Scientific Advisory Board and support Mogrifiy’s executive team in … more ➔
